
Next-Generation Retinal Implant via Bioengineering (eRETINA)
Retinal degenerative diseases, such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP), affect approximately 200 million and 1.5 million people worldwide, respectively. These conditions lead to the progressive loss of retinal cells, ultimately resulting in irreversible vision impairment. …
Read more...